BDBM320334 (2S)-4-{5-[(S)-(2-Fluorophenyl)(oxan-4-yl)methyl]-3-[4-(2H3)methyl-1-methyl-1H-1,2,3-triazol-5-yl]-5H-pyrido[3,2-b]indol-8-yl}-2-methyl-11λ6,4-thiomorpholine-1,1-dione::US10174024, Example 52
SMILES: C[C@H]1CN(CCS1(=O)=O)c1ccc2n([C@@H](C3CCOCC3)c3ccccc3F)c3cc(cnc3c2c1)-c1c(C)nnn1C
InChI Key: InChIKey=KXLKZGBBDBNVAJ-WEZXKFLESA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM320334 ((2S)-4-{5-[(S)-(2-Fluorophenyl)(oxan-4-yl)methyl]-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The binding of compounds to bromodomain BRD4 (44-168), BRD4 (333-460), and BRD4 (1-477 or 44-460) was assessed using a time resolved fluorescent reso... | US Patent US10174024 (2019) BindingDB Entry DOI: 10.7270/Q2319XZ1 | |||||||||||
More data for this Ligand-Target Pair |